T. Sekiya

发表

Frequent Germline and Somatic Single Nucleotide Variants in the Promoter Region of the Ribosomal RNA Gene in Japanese Lung Adenocarcinoma Patients

Shujiro Okuda, P. Schraml, A. Miyashita, 2020, Cells.

Phase II Trial of the Combination of Alectinib with Bevacizumab in Alectinib Refractory ALK-Positive Nonsquamous Non-Small-Cell Lung Cancer (NLCTG1501)

K. Nishio, Daisuke Ishikawa, T. Sekiya, 2022, Cancers.

DDX3X mediates EGFR-TKI resistance through VEGFR signaling

Takaaki Masuda, T. Sekiya, Aya Ohtsubo, 2021 .

Seihaito, a Kampo medicine, attenuates IL-13-induced mucus production and goblet cell metaplasia.

T. Sekiya, K. Murakami, Y. Isohama, 2024, Journal of pharmacological sciences.